Atomoxetine (brand name: Strattera) is a norepinephrine reuptake inhibitor
approved for the treatment of attention deficit hyperactivity disorder (ADHD).
While your child is taking atomoxetine, you should watch his or her behavior very
carefully, especially at the beginning of treatment and any time his or her dose ...
Jun 16, 2015 ... Learn about the prescription medication Strattera (Atomoxetine HCl), drug uses,
dosage, side effects, drug interactions, warnings, reviews and ...
Pictures of Strattera (Atomoxetine HCl), drug imprint information, side effects for
Jul 24, 2015 ... Atomoxine (marketed as Strattera) is currently approved in the United States to
treat attention-deficit/hyperactivity disorder (ADHD) in children, ...
Apr 6, 2015 ... Information on the drug Atomoxetine (Strattera), used to treat attention deficit
hyperactivity disorder (ADHD) in children, teens, and adults.
Medscape - Attention deficit hyperactivity disorder (ADHD)-specific dosing for
Strattera (atomoxetine), frequency-based adverse effects, comprehensive ...
Atomoxetine is the first non-stimulant drug approved for the treatment of attention-
deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride ...
Abstract. Atomoxetine is a novel, non-stimulant, highly selective noradrenaline
reuptake inhibitor that has been studied for use in the treatment of attention ...
Atomoxetine and stimulants have both been demonstrated effective as single ...
Four cases are presented to illustrate how atomoxetine and stimulants can be ...